Klaus Hamprecht

6.7k total citations
133 papers, 4.6k citations indexed

About

Klaus Hamprecht is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Klaus Hamprecht has authored 133 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Epidemiology, 34 papers in Infectious Diseases and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Klaus Hamprecht's work include Cytomegalovirus and herpesvirus research (110 papers), Herpesvirus Infections and Treatments (39 papers) and Parvovirus B19 Infection Studies (26 papers). Klaus Hamprecht is often cited by papers focused on Cytomegalovirus and herpesvirus research (110 papers), Herpesvirus Infections and Treatments (39 papers) and Parvovirus B19 Infection Studies (26 papers). Klaus Hamprecht collaborates with scholars based in Germany, United States and Slovakia. Klaus Hamprecht's co-authors include Gerhard Jahn, Rangmar Goelz, Jens Maschmann, Christian P. Speer, Klaus Dietz, Matthias Vochem, Rupert Handgretinger, Peter Lang, Tobias Feuchtinger and Michael Schumm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

Klaus Hamprecht

128 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Hamprecht Germany 36 3.6k 1.2k 923 874 773 133 4.6k
David A. Lammas United Kingdom 26 1.9k 0.5× 1.7k 1.4× 58 0.1× 339 0.4× 2.0k 2.6× 59 4.8k
Hiroyuki Tsutsumi Japan 30 1.5k 0.4× 1.1k 0.9× 134 0.1× 94 0.1× 588 0.8× 206 3.4k
Anthony Hayward United States 40 2.5k 0.7× 452 0.4× 158 0.2× 90 0.1× 2.1k 2.7× 155 5.3k
O. Brad Spiller United Kingdom 36 1.2k 0.3× 443 0.4× 163 0.2× 77 0.1× 939 1.2× 121 3.1k
Eva Sverremark‐Ekström Sweden 31 770 0.2× 308 0.3× 223 0.2× 412 0.5× 1.6k 2.1× 92 3.4k
Peter C. Melby United States 42 2.0k 0.5× 615 0.5× 59 0.1× 353 0.4× 1.3k 1.7× 111 5.1k
Steve Kohl United States 34 1.7k 0.5× 663 0.5× 106 0.1× 103 0.1× 1.5k 1.9× 141 3.9k
Subash Babu India 41 2.0k 0.5× 3.5k 2.9× 89 0.1× 143 0.2× 1.7k 2.3× 247 5.8k
Martha M. Eibl Austria 31 686 0.2× 642 0.5× 87 0.1× 198 0.2× 1.8k 2.3× 175 3.5k
Sophie Alain France 31 2.5k 0.7× 999 0.8× 261 0.3× 39 0.0× 195 0.3× 154 3.4k

Countries citing papers authored by Klaus Hamprecht

Since Specialization
Citations

This map shows the geographic impact of Klaus Hamprecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Hamprecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Hamprecht more than expected).

Fields of papers citing papers by Klaus Hamprecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Hamprecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Hamprecht. The network helps show where Klaus Hamprecht may publish in the future.

Co-authorship network of co-authors of Klaus Hamprecht

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Hamprecht. A scholar is included among the top collaborators of Klaus Hamprecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Hamprecht. Klaus Hamprecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldeck, David, Tamàs Fülöp, Claudia Schulte, et al.. (2025). Frequencies of Circulating Immune Cells in Patients with Parkinson’s Disease: Correlation with MDS-UPDRS Scores. Journal of Integrative Neuroscience. 24(2). 26393–26393.
2.
Businger, Ramona, et al.. (2023). Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1. Antiviral Research. 217. 105689–105689. 4 indexed citations
3.
Schneidawind, Dominik, Susanne S. Renner, Daniel Atar, et al.. (2022). Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(8). 513.e1–513.e4. 4 indexed citations
4.
Ruétalo, Natalia, Ramona Businger, Karina Althaus, et al.. (2021). Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients. mSphere. 6(1). 12 indexed citations
5.
Kagan, Karl Oliver, Martin Enders, Markus Hoopmann, et al.. (2021). Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study. Ultrasound in Obstetrics and Gynecology. 57(4). 560–567. 32 indexed citations
6.
Dhingra, Akshay, Elias Hage, Tina Ganzenmueller, et al.. (2019). Molecular Evolution of Human Adenovirus (HAdV) Species C. Scientific Reports. 9(1). 1039–1039. 112 indexed citations
7.
8.
Hamprecht, Klaus, et al.. (2014). Intrafamilial transmission of human cytomegalovirus (HCMV): Long-term dynamics of epitope-specific antibody response in context of avidity maturation. Journal of Clinical Virology. 60(2). 119–126. 9 indexed citations
9.
Nováková, V., et al.. (2014). Severe postnatal CMV colitis with an extensive colonic stenosis in a 2-month-old male immunocompetent term infant infected via breast milk. Journal of Clinical Virology. 59(4). 259–263. 16 indexed citations
10.
Kagan, Karl Oliver, et al.. (2013). Effective management and intrauterine treatment of congenital cytomegalovirus infection: review article and case series. The Journal of Maternal-Fetal & Neonatal Medicine. 27(2). 209–214. 14 indexed citations
11.
Bachmann, Robert, Klaus Hamprecht, Jessica Lange, et al.. (2013). Successful ganciclovir treatment of primary cytomegalovirus infection containing the UL97 mutation N510S in an intestinal graft recipient. Infection. 41(4). 875–879. 3 indexed citations
12.
13.
Arellano‐Galindo, José, et al.. (2010). The role of cytomegalovirus infection and disease in pediatric bone marrow transplant recipients in Mexico City in the context of viral drug resistance. Pediatric Transplantation. 15(1). 103–111. 7 indexed citations
14.
Wiechers, Cornelia, et al.. (2007). Apparently non-specific results found using a norovirus antigen immunoassay for fecal specimens from neonates. Journal of Perinatology. 28(1). 79–81. 15 indexed citations
15.
Bissinger, Alfred Lennart, Hermann Einsele, Klaus Hamprecht, et al.. (2005). Infectious pulmonary complications after stem cell transplantation or chemotherapy: Diagnostic yield of bronchoalveolar lavage. Diagnostic Microbiology and Infectious Disease. 52(4). 275–280. 25 indexed citations
16.
17.
Eckle, Tobias, Gerhard Jahn, & Klaus Hamprecht. (2002). High Impact of an Expanded Restriction Fragment Length Polymorphism Assay on Detection of Ganciclovir-Resistant UL97 Mutants of Human Cytomegalovirus. Antimicrobial Agents and Chemotherapy. 47(1). 442–443. 9 indexed citations
18.
Prix, Lothar, et al.. (1999). Comprehensive Restriction Analysis of the UL97 Region Allows Early Detection of Ganciclovir‐Resistant Human Cytomegalovirus in an Immunocompromised Child. The Journal of Infectious Diseases. 180(2). 491–495. 35 indexed citations
19.
Hamprecht, Klaus & F. A. Anderer. (1990). Autolytic generation of dialyzable components in extracts of viscum album exhibiting different mechanisms of enhancement of human nk cytotoxicity against tumor cells. International Journal of Immunopathology and Pharmacology. 3(2). 63–74. 1 indexed citations
20.
Probst, Hans Christian, Klaus Hamprecht, & Volker Gekeler. (1983). Replicon initiation frequency and intracellular levels of ATP, ADP, AMP and of diadenosine 5′,5‴-P1,P4-tetraphosphate in Ehrlich ascites cells cultured aerobically and anaerobically. Biochemical and Biophysical Research Communications. 110(2). 688–693. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Lammas Breakdown of academic impact, for papers by Hiroyuki Tsutsumi Breakdown of academic impact, for papers by Anthony Hayward Breakdown of academic impact, for papers by O. Brad Spiller Breakdown of academic impact, for papers by Eva Sverremark‐Ekström Breakdown of academic impact, for papers by Peter C. Melby Breakdown of academic impact, for papers by Steve Kohl Breakdown of academic impact, for papers by Subash Babu Breakdown of academic impact, for papers by Martha M. Eibl Breakdown of academic impact, for papers by Sophie Alain
Rankless by CCL
2026